Peripheral stent LIFESTENT® SOLO™

LifeStent™ Solo™ Vascular Stent System FDA-approved for the SFA and full popliteal artery Features: Longest lesion length indication (up to 240 mm)1 Proven performance in long lesions2 Designed for enhanced distal and proximal stent placement accuracy Treat longer lesions with one stent About LifeStent™ Solo™ Vascular Stent The LifeStent™ Solo™ Vascular Stent is the first commercially available 200 mm stent in the U.S. and potentially enables a single-stent solution. The LifeStent™ Solo™ Vascular Stent has sustained effectiveness up to three years in longer lesions. Furthermore, its enhanced delivery system is designed to reduce delivery system-dependent stent compression or elongation and enhance deployment accuracy. The LifeStent™ Vascular Stent Systems, in varying sizes, have been studied in more than ten clinical trials in the United States and globally. The LifeStent™ Solo™ Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 – 6.5mm. The LifeStent™ Vascular Stent is the only FDA-approved stent for the SFA and full popliteal artery. The LifeStent™ Solo™ Vascular Stent is available in 6 mm and 7 mm diameters and 200 mm in length. Additionally, the LifeStent™ Vascular Stent is available in 5 mm, 6 mm, and 7 mm diameters; and 20 mm to 170 mm in length. To learn more about the LifeStent™ Vascular Stent,